NEW YORK (GenomeWeb) – The Perelman School of Medicine at the University of Pennsylvania has received a $7.3 million grant from the National Cancer Institute for three research projects targeting genes and proteins involved in of esophageal cancer.

The grant renews an NCI-funded program at the Perelman school that has been ongoing for 10 years, and is the only program of its kind that NCI supports that is focused on finding treatments and biomarkers for esophageal cancer, the medical school said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An Australian study of personalized medicine has run into problems as it recruits patients.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.